Literature DB >> 25559958

Epidemiology and microbiology of nosocomial bloodstream infections: analysis of 482 cases from a retrospective surveillance study.

Jian-nong Wu1, Tie-er Gan, Yue-xian Zhu, Jun-min Cao, Cong-hua Ji, Yi-hua Wu, Bin Lv.   

Abstract

In many traditional Chinese medicine (TCM) hospitals, most patients are elderly with chronic diseases. Nosocomial bloodstream infections (nBSIs) are an important cause of morbidity and mortality. A retrospective surveillance study was performed to examine the epidemiology and microbiology of nBSIs in a TCM hospital from 2009 to 2011. A total of 482 patients with nBSIs were included in the study period. The incidence rate was 5.7/1000 admissions. Escherichia coli (25.5%) was the most common Gram-negative and coagulase-negative staphylococcus (CoNS) (14.1%) was the most common Gram-positive organism isolated. One-third of the E. coli and Klebsiella pneumoniae isolated from the nBSIs were the third-generation cephalosporin-resistant. Half of the Acinetobacter species isolates were resistant to imipenem. Of all the CoNS isolates, 90.7% were resistant to methicillin. Carbapenems and glycopeptide were the most frequently used for nBSI therapy. Only about one-third of patients (157/482) received appropriate empirical therapy. Septic shock, hemodialysis, Pitt bacteremia score >4, urinary tract infection, and appropriate empirical therapy were most strongly associated with 28-d mortality. The incidence of nBSIs was low in the TCM hospital but the proportion of nBSIs due to antibiotic-resistant organisms was high. A high Pitt bacteremia score was one of the most important risk factors for mortality in nBSIs. Therefore, the implementation of appropriate empirical therapy is crucial to improve the clinical outcome of nBSIs.

Entities:  

Keywords:  Epidemiology; Microbiology; Nosocomial bloodstream infection; Traditional Chinese medicine hospital

Mesh:

Substances:

Year:  2015        PMID: 25559958      PMCID: PMC4288947          DOI: 10.1631/jzus.B1400108

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  29 in total

1.  Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.

Authors:  Pilar Retamar; María M Portillo; María Dolores López-Prieto; Fernando Rodríguez-López; Marina de Cueto; María V García; María J Gómez; Alfonso Del Arco; Angel Muñoz; Antonio Sánchez-Porto; Manuel Torres-Tortosa; Andrés Martín-Aspas; Ascensión Arroyo; Carolina García-Figueras; Federico Acosta; Juan E Corzo; Laura León-Ruiz; Trinidad Escobar-Lara; Jesús Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients.

Authors:  M Hilf; V L Yu; J Sharp; J J Zuravleff; J A Korvick; R R Muder
Journal:  Am J Med       Date:  1989-11       Impact factor: 4.965

3.  Nosocomial bloodstream infection in Songklanagarind Hospital: outcome and factors influencing prognosis.

Authors:  Thanaporn Hortiwakul; Somkid Nagij; Sarunyou Chusri; Khachornsakdi Silpapojakul
Journal:  J Med Assoc Thai       Date:  2012-02

4.  Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.

Authors:  Elizabeth A Neuner; Jun-Yen Yeh; Gerri S Hall; Jennifer Sekeres; Andrea Endimiani; Robert A Bonomo; Nabin K Shrestha; Thomas G Fraser; David van Duin
Journal:  Diagn Microbiol Infect Dis       Date:  2011-04       Impact factor: 2.803

5.  Existing data sources for clinical epidemiology: The North Denmark Bacteremia Research Database.

Authors:  Henrik C Schønheyder; Mette Søgaard
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

6.  The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis.

Authors:  M P Weinstein; J R Murphy; L B Reller; K A Lichtenstein
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

7.  Source of infection and other factors associated with case fatality in community-acquired bacteremia--a Danish population-based cohort study from 1992 to 1997.

Authors:  G Pedersen; H C Schønheyder; H T Sørensen
Journal:  Clin Microbiol Infect       Date:  2003-08       Impact factor: 8.067

8.  The distinct category of healthcare associated bloodstream infections.

Authors:  Ryan Lenz; Jenine R Leal; Deirdre L Church; Daniel B Gregson; Terry Ross; Kevin B Laupland
Journal:  BMC Infect Dis       Date:  2012-04-09       Impact factor: 3.090

9.  Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007.

Authors:  Ji-Guang Ding; Qing-Feng Sun; Ke-Cheng Li; Ming-Hua Zheng; Xiao-Hui Miao; Wu Ni; Liang Hong; Jin-Xian Yang; Zhan-Wei Ruan; Rui-Wei Zhou; Hai-Jiao Zhou; Wen-Fei He
Journal:  BMC Infect Dis       Date:  2009-07-25       Impact factor: 3.090

10.  Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections.

Authors:  Mark Melzer; Catherine Welch
Journal:  Postgrad Med J       Date:  2013-03-21       Impact factor: 2.401

View more
  3 in total

1.  Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis.

Authors:  Yuan-Pin Hung; Ching-Chi Lee; Wen-Chien Ko
Journal:  Front Med (Lausanne)       Date:  2022-05-30

2.  Impact of multicenter unified enhanced environmental cleaning and disinfection measures on nosocomial infections among patients in intensive care units.

Authors:  Jing Huang; Can Cui; Shuli Zhou; Ming Chen; Hao Wu; Ronghua Jin; Xinyue Chen
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

3.  Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study.

Authors:  Qiang Zhu; Yan Yue; Lichen Zhu; Jiewei Cui; Minghui Zhu; Liangan Chen; Zhen Yang; Zhixin Liang
Journal:  Antimicrob Resist Infect Control       Date:  2018-09-03       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.